We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Near-Infrared Set-Up Evaluated for Dried Blood Spot Hematocrit

By LabMedica International staff writers
Posted on 11 Nov 2021
Print article
Image: The NIRFlex N-500 Fourier Transformation spectrometer (Photo courtesy of Büchi Labortechnik)
Image: The NIRFlex N-500 Fourier Transformation spectrometer (Photo courtesy of Büchi Labortechnik)
Capillary dried blood sampling, where samples are obtained from a finger or heel prick, has many advantages over traditional blood sampling. The best-known dried blood sampling technique is the generation of dried blood spots (DBS) on filter paper.

Conventional DBS cards remain valuable to collect dried blood microsamples, not in the least because DBS sampling is well known in the newborn and pediatrics field, the analysis can easily be automated and the cost is low. Amongst the approaches that were developed to cope with this issue, is the hematocrit (Hct) prediction of DBS using near-infrared (NIR) spectroscopy.

Clinical Scientists at the Ghent University Hospital (Ghent, Belgium) and their colleagues collected blood from 12 healthy volunteers via finger prick and each volunteer provided three capillary DBS and three corresponding liquid capillary samples, the latter being collected via heparinized microcapillaries. Left-over venous EDTA-anti-coagulated patient samples were used to generate DBS by pipetting 25 µL of whole blood onto Whatman 903 filter paper.

The team determined Hct L/L (liter of cells/liter of blood) values with a Sysmex XN-5000 hematology analyzer (Sysmex, Kobe, Japan). The Hct of liquid capillary blood samples was determined via centrifugation in a Hct-centrifuge (5 minutes, 12,000 rpm), and then measured using a micro-hematocrit reader (Hawksley, Lancing, UK). NIR measurements were performed on a NIRFlex N-500 Fourier Transformation spectrometer equipped with a fiber optics solids cell N500-007 (Büchi Labortechnik, Flawil, Switzerland). The results obtained via NIR for the DBS validation set (n = 49; singlicate analysis), measured at Day 0 and Day 5, were compared to those obtained with the hematology analyzer, being the standard method.

Using left-over EDTA-anticoagulated patient samples, the accuracy and precision, stability, and robustness were assessed. Furthermore, applicability of the method on capillary DBS was evaluated via finger prick samples. The investigators reported that the method validation amply met the pre-set acceptance criteria, with a maximum total precision of 4.5% and bias of 0.012 L/L. Also storage did not relevantly affect the Hct prediction, except for storage at 60 °C. The analysis of samples with a high hemolytic/icteric/lipemic index (HIL)-index showed that only lipemia had a significant effect on the Hct predictions. The mean difference was 0.035 L/L, which was considered acceptable.

The authors concluded that a commercially available NIR set-up was extensively and successfully validated, allowing non-contact Hct prediction of DBS with excellent accuracy and precision. This allows to correct for the Hct-based bias observed in partial-punch DBS analysis and the set-up of blood-plasma conversion factors, increasing the application potential of patient-centric sampling. The study was published on October 5, 2021 in the journal Clinica Chimica Acta.

Related Links:
Ghent University Hospital
Büchi Labortechnik

Gold Supplier
Molecular Diagnostic System
Singuway 9600 Pro
Molecular Diagnostic Platform
Cardiovascular Disease POC Analyzer
cobas h 232 POC System
Auto Multiparameter POC Analyzer
Triage MeterPro

Print article



view channel
Image: Atellica Solution (Photo courtesy of Siemens Healthineers)

Siemens Introduces New Intelligent, Integrated IVD Solutions Virtually at EUROMEDLAB 2021

Siemens Healthineers (Erlangen, Germany) introduced new intelligent, integrated IVD solutions virtually at the XXIV IFCCEFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab... Read more


view channel
Image: The Luminex 200 Instrument System sets the standard for multiplexing, providing the ability to perform up to 100 different tests in a single reaction volume on a flow cytometry-based platform (Photo courtesy of Luminex Corp)

Inflammatory Cytokines Measured in Infants Born to Preterm Preeclamptic Mothers

Preeclampsia is both a vascular and inflammatory disorder. The pathophysiology of preeclampsia is complex and rooted in the interplay between maternal and placental factors with the key characteristics... Read more


view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more


view channel
Image: The Ventana BenchMark Ultra autostainer is for cancer diagnostics with automation and the test menu include IHC, ISH, and FITC tests (Photo courtesy of Ventana Medical System)

Specific Biomarker Investigated for Triple-Negative Breast Cancer Diagnosis

Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression and comprises a heterogeneous... Read more


view channel

Global Lateral Flow Assay Market to Reach Nearly USD 6.5 Billion by 2031 Due to Surge in Demand for Rapid POC Testing

The global lateral flow assay market is projected to grow at a CAGR of around 5% from USD 3.7 billion in 2020 to over USD 6.4 billion by 2031, driven by the growing adoption of home-based lateral flow... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.